Doris Helbig (D Helbig)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Combination Therapy

Top Venues

Cancer immunology, immunotherapy : CII

Experimental dermatology

Journal of cutaneous pathology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Melanie Schwab, Sabrina Lohr, Jakob Schneider, Michaela Kaiser, Damir Krunic, Doris Helbig, Cyrill Géraud, Peter Angel
Podoplanin is required for tumor cell invasion in cutaneous squamous cell carcinoma. Experimental dermatology 30 (11) (2021)
Sebastian Klein, Alexander Quaas, Ka-Won Noh, Maria Cartolano, Nima Abedpour, Cornelia Mauch, Jennifer Quantius, Hans Christian Reinhardt, Reinhard Buettner, Martin Peifer, Doris Helbig
Integrative Analysis of Pleomorphic Dermal Sarcomas Reveals Fibroblastic Differentiation and Susceptibility to Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2020)
Sebastian Klein, Cornelia Mauch, Svenja Wagener-Ryczek, Maximilian Schoemmel, Reinhard Buettner, Alexander Quaas, Doris Helbig
Immune-phenotyping of pleomorphic dermal sarcomas suggests this entity as a potential candidate for immunotherapy. Cancer immunology, immunotherapy : CII 68 (6) (2019)
Oana-Diana Persa, C Loquai, M Wobser, M Baltaci, S Dengler, A Kreuter, A Volz, M Laimer, M Emberger, M Doerler, C Mauch, Doris Helbig
Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomas. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (8) (2019)
Doris Helbig, Cornelia Mauch, Reinhard Buettner, Alexander Quaas
Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas. Journal of cutaneous pathology 45 (12) (2018)